Myomo (MYO) Total Debt Growth (3y) (2020)
Myomo (MYO) Total Debt Growth (3y) (2020) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.39 Bn | 174.10 Bn | 6.27 Bn | 26.30% |
| 2 | Stryker | 128.38 Bn | 125.50 Bn | 3.81 Bn | 4.07% |
| 3 | Medtronic | 107.68 Bn | 98.46 Bn | 6.41 Bn | 4.70% |
| 4 | Boston Scientific | 67.98 Bn | 66.53 Bn | 3.61 Bn | 6.99% |
| 5 | Edwards Lifesciences | 47.81 Bn | 44.13 Bn | 1.29 Bn | 0.11% |
| 6 | GE HealthCare Technologies | 28.53 Bn | 26.25 Bn | 1.98 Bn | -0.32% |
| 7 | Dexcom | 28.35 Bn | 27.24 Bn | 750.30 Mn | - |
| 8 | Smith & Nephew | 26.78 Bn | 26.20 Bn | - | 5.42% |
| 9 | Koninklijke Philips | 25.34 Bn | 22.21 Bn | 2.07 Bn | 2.61% |
| 10 | Myomo | 43.01 Mn | 24.04 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | -55.37% |